Coronary Disease Study Ignores B Vitamin Benefits, Casts Shadow On Industry
This article was originally published in The Tan Sheet
Executive Summary
A study showing no benefit from vitamin B and folic acid supplementation on patients with coronary artery disease says little about the nutrients' potential positive cardiovascular effects on a healthy population, industry stakeholders say
You may also be interested in...
Vitamin B Study Latest To Miss Prevention With Healthy Population – Industry
A recent study on vitamin B supplementation's effect on cardiovascular disease in a high-risk population is the latest example of supplement research asking the wrong question, dietary supplement industry stakeholders say
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.